Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvancePCS Gives 80% Of Rebates To Clients, Sees Discounts Increasing

Executive Summary

AdvancePCS retains less than 20% of manufacturer rebates, the pharmacy benefit management company told a July 25 conference call

You may also be interested in...



Caremark/AdvancePCS Merger Will Give Company Half Medco’s Mail Capacity

Caremark will have about half of Medco's mail-order prescription capacity following the proposed acquisition of AdvancePCS

AdvancePCS Nears End Of Employee Interviews In Government Investigation

The Philadelphia U.S. Attorney's Office will finish AdvancePCS employee interviews in its investigation into the PBM's practices by the end of March, the company told a Jan. 29 analyst call

AdvancePCS Nears End Of Employee Interviews In Government Investigation

The Philadelphia U.S. Attorney's Office will finish AdvancePCS employee interviews in its investigation into the PBM's practices by the end of March, the company told a Jan. 29 analyst call

Related Content

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel